National Institute of Mental Health

Narrow WE, Regier DA, Rae DS, et al (1993). Use of services by persons with mental and addictive disorders. Findings from the National Institute of Mental Health Epidemiologic Catchment Area Program. 

This work was supported in part by National Institute of Mental Health Research Scientist Development Award MH00188, National Institute on Drug Abuse Awards DA 02925 and DA 04398, and a Parkinson s Disease Summer Fellowship. 

In a study promoted by the National Institute of Mental Health (NIMH) the Hutterites showed high rates of psychosis (Eaton 8c Weil, 1955). Nevertheless, a later re-analysis of the data using DSM-III-R diagnostic criteria (American Psychiatric Association [APA], 1980) showed that the rate of major depression was four times higher than that of schizophrenia (Torrey, 1995). 

Tung, T. M. (1985). Psychiatric care for Southeast Asian patients how different is different In T. Owan, B. Bliatout, K. M. Lin etal, eds., Southeast Asian Mental Health Treatment, Prevention, Services and Research. Rockville, MD National Institute of Mental Health. 

Iproniazid and imipramine seemed to work as antidepressants, but how did they achieve their effects It would be another decade before the chemical-imbalance theory was launched. In 1965, Joseph Schildkraut at the National Institute of Mental Health in Washington, DC, published a groundbreaking paper in which he argued that depression was caused by a deficiency of the neurotransmitter norepinephrine in the gaps between neurons in the brain.8 Two years later Alec Coppen, a physician at West Park Hospital in Surrey, published another version of the chemical-imbalance theory. His version differed from Schildkraut s in that it put most of the blame on a different neurotransmitter, emphasizing serotonin rather than norepinephrine as the neurotransmitter that was lacking.9... 

Meyer, Bjorn, Paul A. Pilkonis, Janice L. Krupnick, Matthew K Egan, SamuelJ. Simmens, and Stuart M. Sotsky, Patient Alliance Treatment Expectancies, and Outcome Further Analyses, From the National Institute of Mental Health Treatment, of Depression Collaborative Research Program , Journal of Consulting and Clinical Psychology 70, no. 4 (2002), 1051-55... 

National Institute of Mental Health Collaborative Study Group (1964). Phenothiazine treatment in acute schizophrenia. Archives of General Psychiatry, 246-261. 

Laboratory of Molecular Pathology National Institute of Mental Health Building 49, Room B1EE16 49 Convent Drive MCS 4405 Bethesda, MD 20892-4405 USA... 

National Institute of Mental Health (NIMH). Eating Disorders Facts About Eating Disorders and the Search for Solutions ... 

Director Mood Anxiety Disorders Program Chief, Laboratory of Molecular Pathophysiology National Institute of Mental Health National Institutes of Health Building 1, Room 3B310,1 Center Drive Bethesda, Maryland 20892-0135... 

I would also like to thank the Psychology Department at Princeton University and the National Institute of Mental Health for various forms of support which made this project feasible. I owe a special debt of gratitude to Ms. Arlene Kronewitter for her good humor and outstanding secretarial skills. 

Robins, L. N., Helzer, J. E., Croughan, J., Ratcliff, K. S. (1981). National Institute of Mental Health Diagnostic Interview Schedule Its history, characteristics, and validity. Archives of General Psychiatry, 38, 381-389. 

Jenssen, T. A. (1978) Display diversity in anoline lizards and problems in interpretation. In N. Greenberg and D. Maclean (Eds.), Behavior and Neuroethology of Lizards. National Institute of Mental Health, Washington, D.C. pp. 269-285. 

Depression, a treatable condition that affects nearly five million seniors, also goes undetected by some healthcare providers. Some healthcare professionals view depression as just part of getting old. Untreated, this illness can have serious, even fatal consequences. According to the National Institute of Mental Health, older Ameri-(40) cans account for a disproportionate share of suicide deaths, making up 18% of suicide deaths in 2000. Healthcare providers could play a vital role in preventing this outcome—several studies have shown that up to 75 % of seniors who die by suicide visited a primary care physician within a month of their death. 

US National Institute of Mental Health, anxiety (in particular generalized anxiety disorder or GAD) and depression are the most prevalent mental illnesses. In the United States alone, an estimated 4 million adults suffer from GAD and nearly 19 million adults are affected by depressive disorders. As GAD and depression are often present together, most patients suffering from these disorders are treated with the same drugs [1]. 

As the hounding continued, Harry at first claimed that the A.D. Little cmtracts were essentially limited to supplying about six pounds of a potent synthetic relative of THC to the National Institutes of Mental Health for 75,000. Dr. Bob Petersen, speaking for NIMH, immediately expressed shock and surprise that anyone might suppose that such a compound could have any military applications. 

Cyclophosphamide VA Medical Research Services National Institute of Mental Health... 

Section on Developmental Genetic Epidemiology, Mood and Anxiety Disorders Program, National Institute of Mental Health/NIH, Building 35, Room 1A201, 35 Convent Drive, MSC 3720, 20892-3720, Bethesda MD, USA kathleen.merikangas nih.gov... 

Mood and Anxiety Disorders Research Program, National Institute of Mental Health/NIH, 15K North Drive, MSC 2670, Bethesda MD, 20892-2670, USA Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1102,... 

The preliminary findings of a relationship between serotonin S-HTja receptor genotype and atypical antipsychotic responsiveness in schizophrenia warrant replication and could be extended to children and adolescents with autism. Investigation along these lines has been included in the (National Institute of Mental Health (NIMH)-sponsored multicenter study of risperidone in autism (Arnold et ah, 2000). 

Despite the overwhelming evidence for short-term effectiveness, only recently have studies begun to address long-term benefits of stimulant treatments. Prospective randomized controlled trials with durations of 12 to 24 months and doses up to 60 mg/day of MPH have been conducted to address this issue. The largest of these studies, the National Institute of Mental Health (NIMH)-sponsored Multimodal Treatment Study of Attention-Deficit Hyperactivity Disorder (MTA Study), showed that stimulants (either by themselves or in combination with behavioral treatments) lead to stable, long-term improvements in ADHD symptoms as long as the medication is taken (MTA Cooperative Group, 1999). 

It is recommended that neurological side effects be monitored carefully throughout the course of antipsychotic treatment. Rating scales can assist in monitoring for EPS and the involuntary movements seen in tardive dyskinesia. These include the Neurological Rating Scale (Simpson and Angus, 1970), the Barnes Akathisia Scale (Barnes, 1989), and the Abnormal Involuntary Movement Scale ([AIMS] National Institute of Mental Health, 1985). 

Norquist, G.S., and Magruder, K.M. (1998) Views from funding agencies. National Institute of Mental Health. Med Care 36 1306-1308. 

Selective serotonin reuptake inhibitors. Currently available selective serotonin reuptake inhibitors (SSRIs) include fluoxetine, paroxetine, sertraline, fluvoxamine, and citalopram. At present, expert opinion does not support the usefulness of these serotonergic compounds in the treatment of core ADHD symptoms (National Institute of Mental Health, 1996). Nevertheless, because of the high rates of comorbidity in ADHD, these compounds are frequently combined with effective anti-ADHD agents (see Combined Pharmacotherapy, below). Since many psychotropics are metabolized by the cytochrome P450 system (Nemeroff et ah, 1996), which in turn can be inhibited by the SSRIs, caution should be exercised when combining agents, such as the TCAs, with SSRIs. 

---